Literature DB >> 9244333

Biological warfare. A historical perspective.

G W Christopher1, T J Cieslak, J A Pavlin, E M Eitzen.   

Abstract

The deliberate use of microorganisms and toxins as weapons has been attempted throughout history. Biological warfare has evolved from the crude use of cadavers to contaminate water supplies to the development of specialized munitions for battlefield and covert use. The modern development of biological agents as weapons has paralleled advances in basic and applied microbiology. These include the identification of virulent pathogens suitable for aerosol delivery and industrial-scale fermentation processes to produce large quantities of pathogens and toxins. The history of biological warfare is difficult to assess because of a number of confounding factors. These include difficulties in verification of alleged or attempted biological attacks, the use of allegations of biological attacks for propaganda purposes, the paucity of pertinent microbiological or epidemiologic data, and the incidence of naturally occurring endemic or epidemic diseases during hostilities. Biological warfare has been renounced by 140 nations, primarily for strategic and other pragmatic reasons. International diplomatic efforts, including the 1972 Biological Weapons Convention, have not been entirely effective in preventing the enhancement and proliferation of offensive biological warfare programs. The threats posed by biological weapons are likely to continue into the future.

Entities:  

Mesh:

Year:  1997        PMID: 9244333

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  107 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus.

Authors:  D R Smith; C A Rossi; T M Kijek; E A Henchal; G V Ludwig
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Biological Warfare: Implications for Antimicrobial Use.

Authors:  Ethan Rubinstein; Itzhak Levi
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

4.  Preemptive biopreparedness: can we learn anything from history?

Authors:  E Fee; T M Brown
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

5.  Pulmonary Manifestations of Bioterrorism.

Authors:  Renuka Heddurshetti; Wadchara Pumpradit; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

6.  Biological warfare.

Authors:  J Suchard
Journal:  West J Med       Date:  1999-04

Review 7.  Recognizing the real threat of biological terror.

Authors:  Richard P Wenzel
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

Review 8.  [Bioterrorism and primary care].

Authors:  M A Mayer Pujadas; M J Alvarez Pasquín; J Gómez Marco; J Redondo Sánchez; J Muñoz Gutiérrez; M Cereceda Ferrés; C Batalla Martínez; E Comín Bertrán; A Pareja Bezares; R Piñeiro Guerrero; V Niño Martín; J Arranz Izquierdo; P Carceller; E Nodar Martín; J Ortega Martínez; J Vázquez Villegas
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

9.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

10.  Generation of the Brucella melitensis ORFeome version 1.1.

Authors:  Amélie Dricot; Jean-François Rual; Philippe Lamesch; Nicolas Bertin; Denis Dupuy; Tong Hao; Christophe Lambert; Régis Hallez; Jean-Marc Delroisse; Jean Vandenhaute; Ignacio Lopez-Goñi; Ignacio Moriyon; Juan M Garcia-Lobo; Félix J Sangari; Alastair P Macmillan; Sally J Cutler; Adrian M Whatmore; Stephanie Bozak; Reynaldo Sequerra; Lynn Doucette-Stamm; Marc Vidal; David E Hill; Jean-Jacques Letesson; Xavier De Bolle
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.